Steroid rosacea

Leyden, J. J.

doi:10.1001/archderm.110.4.619

Cited by 30 publications

(5 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The role of Demodex folliculorum in human dermatopathology and particularly in rosacea has remained controversial [5]. Bonnar et al reported significantly increased mite densities in many types of rosacea including steroid-induced rosacea [15].…”

Section: Discussionmentioning

confidence: 99%

“…Chronic misuse of TCS on the face produced a clinical condition which was described by various names, like light sensitive seborrheid [2], perioral dermatitis [3], rosacea-like dermatitis [4]. steroid rosacea [5], steroid dermatitis resembling rosacea [6], and steroid-induced rosacea-like dermatitis [7]. Since there is no agreement on nomenclature, we prefer to promote the term steroid dermatitis resembling rosacea (SDRR) where it describes the morphology of the disease due to TCS abuse on the face.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Steroid Dermatitis Resembling Rosacea: A Clinical Evaluation of 75 Patients

Hameed

2013

ISRN Dermatology

View full text Add to dashboard Cite

Background. The use of topical steroids on the skin of the face should be carefully evaluated by the dermatologist; however, its misuse still occurs producing dermatological problem resembling rosacea. Objectives. To report the different clinical manifestations of steroid dermatitis resembling rosacea and to discover causes behind abusing topical steroids on the face. Methods. In this prospective observational study, 75 patients with steroid dermatitis resembling rosacea who had history of topical steroid use on their faces for at least 1–3 months were evaluated at the Department of Dermatology, Baghdad Teaching Hospital, between August 2010 and December 2012. Results. The majority of patients were young women who used a combinations of potent and very potent topical steroid for average period of 0.25–10 years. Facial redness and hotness, telangiectasia, and rebound phenomenon with papulopustular eruption were the main clinical presentations. The most common causes of using topical steroid on the face were pigmentary problems and acne through recommendations from nonmedical personnel. Conclusion. Topical steroid should not be used on the face unless it is under strict dermatological supervision.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Steroid Dermatitis Resembling Rosacea: A Clinical Evaluation of 75 Patients

Hameed

2013

ISRN Dermatology

View full text Add to dashboard Cite

show abstract

“…The appearance is of a flaming red, scaly, papule-covered face. [7–9] Multiple pathways including rebound vasodilatation and proinflammatory cytokine release by chronic intermittent steroid exposure induce rosacea-like eruption. [11] The average duration of treatment required to produce adverse effects in most cases is 6 months or more, but it varies and is also potency dependent.…”

Section: Discussionmentioning

confidence: 99%

Steroid - induced rosacea: A clinical study of 200 patients

2011

View full text Add to dashboard Cite

Background:Topical corticosteroids were first introduced for use in 1951. Since then uncontrolled use (abuse) has caused many different reactions resembling rosacea – steroid dermatitis or iatrosacea. Multiple pathways including rebound vasodilatation and proinflammatory cytokine release have been proposed as the mechanism for such reactions.Aim:The aim was to study the adverse effects of topical steroid abuse and the response to various treatment modalities.Materials and Methods:Two hundred patients with a history of topical steroid use on face for more than 1 month were studied clinically and various treatments tried.Results:The duration of topical corticosteroid use varied from 1 month to 20 years with an average of 19.76 months. Majority of patients were using potent (class II) topical steroids for trivial facial dermatoses. The common adverse effects were erythema, telangiectasia, xerosis, hyperpigmentation, photosensitivity, and rebound phenomenon. No significant change in laboratory investigations was seen.Conclusion:A combination of oral antibiotics and topical tacrolimus is the treatment of choice for steroid-induced rosacea.

show abstract

“…On theoret ical grounds we prefer HC 17-B to TA. This preference did not ensue from our trial, probably because its duration was too short; it can, however, be gathered from the literature that fluorinated corticosteroids should not be used on the face [4,6,9,10,14], (2) New patients with untreated and stronger changes may apply a topical nonfluorinated corticosteroid in addition to taking tetracycline at the beginning of treatment. More rapid improvement can thus be ex pected [9,10].…”

Section: Discussionmentioning

confidence: 99%

Comparative Study of Triamcinolone Acetonide and Hydrocortisone 17-Butyrate in Rosacea with Special Regard to the Rebound Phenomenon

Wuite

1976

Dermatology

View full text Add to dashboard Cite

The clinical efficacy and the rebound phenomenon were studied in a left-right double-blind trial comparing triamcinolone acetonide (TA) and hydrocortisone 17-butyrate (HC 17-B, Locoid®). The trial comprised 19 patients with rosacea-like dermatitis of whom 7 did not receive treatment and 12 were pretreated with betamethasone valerate (BMV). Tetracycline was given all the time as additional treatment. Clinically there was no significant difference between TA and HC 17-B. No rebound phenomenon was observed. If corticosteroids are to be used at all in rosacea or rosacea-like dermatitis, preference is given to HC 17-B.

show abstract

Steroid rosacea

Cited by 30 publications

References 1 publication

Steroid Dermatitis Resembling Rosacea: A Clinical Evaluation of 75 Patients

Steroid Dermatitis Resembling Rosacea: A Clinical Evaluation of 75 Patients

Steroid - induced rosacea: A clinical study of 200 patients

Comparative Study of Triamcinolone Acetonide and Hydrocortisone 17-Butyrate in Rosacea with Special Regard to the Rebound Phenomenon

Contact Info

Product

Resources

About